Preparation and in Vitro/in Vivo Evaluation of Bezafibrate Sustained-Release Pellet Capsules

LIU Chun-hui,XU Xiang-yang,CHEN Yun,WANG Yong-qing,ZHOU Jian-ping

DOI: https://doi.org/10.3321/j.issn:1000-5048.2006.05.007

2006-01-01

Abstract:Aim:To prepare bezafibrate sustained-release pellet capsules.Methods:Bezafibrate pellet capsules were prepared by centrifugal granulation technology.The pellets were evaluated by in vitro release and pharmacokinetic profiles in Beagles.Results:By this method,the yield of the pellets in the appropriate size range was 86.5% and bezafibrate loading was 87.8%.The release profile was best fitted to the first kinetics and the values of similar factor(f_(2)) was calculated to be 74.23.After single oral dose in beagles,the main pharmacokinetic parameters of bezafibrate self-made sustained-release pellet capsules were:t_(max)(3.7±0.5)h,c_(max)(36.36±0.98)μg/mL,AUC_(0-∞)(337.83±7.29)μg·h/mL.On the other hand,commercially available bezafibrate sustained tablets(reference tablets) were:t_(max)(4.1±0.4)h,c_(max)(39.66±0.94 )μg/mL,AUC_(0-∞)(327.27±8.97)μg·h/mL.Conclusion:The release of self-made sustained release capsules was similar to that of the imported sustained tablets.The relative bioavailability of the capsule in comparison to the reference tablet was(103.3±2.8)%,and the former were bioequivalent to the latter.